Frontlight ResearchEarly access
Macular degeneration trials, also abroad
220 open Macular degeneration trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) has 5 sites in Austria and runs in 18 countries. If a site near you is full, another one may still take people.
See Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) in all 18 countries